Lv2
126 积分 2024-08-08 加入
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2– Early Breast Cancer
3天前
已完结
Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer
6个月前
已完结
Molecular classification of hormone receptor-positive HER2-negative breast cancer
7个月前
已完结
Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
7个月前
已完结
Proteomic Profiling of Medullary Thyroid Cancer Identifies CAPN1 as a Key Regulator of NF1 and RET Fueled Growth
1年前
已完结
Progastrin-Releasing Peptide and Procalcitonin as Additional Markers in the Diagnostic Workup for Medullary Thyroid Carcinoma
1年前
已完结
皖公网安备34019202002308
